IL1B and cardiovascular disorder: We also chose to quantify the immunoregulatory cytokines, IL-10, which has shown strong potential as a therapeutic target [35,36,37] and IL-1RA, an antagonist of IL-1 even if its therapeutic application in cardiovascular diseases remains unproven [38].